[Perioperative analgesia with continuous peripheral nerve blocks in children].
Recently, regional anaesthesia in children has generated increasing interest. But single injection techniques have a limited duration of postoperative analgesia. Then, continuous peripheral nerve blocks have taken an important position in the anaesthetic arsenal, allowing an effective, safe and prolonged postoperative pain management. As adults, indications for continuous peripheral nerve blocks depend on the analysis of individual benefits/risks ratio. Main indications are intense postoperative pain surgical procedures, with or without postoperative rehabilitation, and complex regional pain syndrome. Contraindications to these procedures are rather similar to those in adults, plus parental and/or children refusal. Continuous peripheral nerve blocks are usually performed under general anaesthesia or sedation in children, and require appropriate equipment in order to decrease the risk of nerve injury. New techniques, such as transcutaneous nerve stimulation or ultrasound guidance, appeared to facilitate nerve and plexus approach identification in paediatric patients. Nevertheless, continuous peripheral nerve block may theoretically mask a compartment syndrome after trauma surgical procedures. Finally, ropivacaine appears to be the most appropriate drug for continuous peripheral nerve blocks in children, requiring low flow rates and concentrations of local anaesthetic. These techniques may facilitate early ambulation by an improved pain management or even postoperative analgesia at home with disposable pumps. One might infer from the current review that excellent pain relief coupled with a reduction of side effects would contribute to improve the quality of life and to decrease the frequency of disabling behavioural modifications in children, sometimes psychologically injured by hospital stay and postoperative pain.
Dadure
C
C
Département d'anesthésie et de réanimation A, centre hospitalier universitaire Lapeyronie, 371, avenue du Doyen-Giraud, 34295 Montpellier, France.
Capdevila
X
X
D000577:Amides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D000698:Analgesia / Q000295:instrumentation / Q000379:methods*; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000768:Anesthesia, General; D001132:Arm / Q000294:innervation / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D020918:Complex Regional Pain Syndromes / Q000628:therapy*; D000075202:Contraindications; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D007223:Infant; D007866:Leg / Q000294:innervation / Q000601:surgery; D009407:Nerve Block / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D059408:Pain Management; D010149:Postoperative Pain / Q000628:therapy*; D000077212:Ropivacaine
D000577:Amides; D018712:Analgesics, Non-Narcotic; D006993:Hypnotics and Sedatives; D000077212:Ropivacaine